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Abstract
Background: Typically, urine and other biological tissues have been analyzed for cocaine (COC) and/or metabolites to 
detect COC usage. COC undergoes numerous biotransformation and degradation reactions. Crack smokers are exposed 
to anhydroecgonine methyl ester (AME), which can be used as an analytical marker for crack smoking. The stability 
of this analyte in human urine has not been studied. In the body, COC is rapidly converted to metabolites by enzymatic 
and chemical processes, the major urinary metabolite being benzoylecgonine (BE). Objectives: This study was carried 
out in order to determine the effects of time and temperature on the stability of cocaine/crack metabolites in human 
urine. Methods: The stability of AME, BE and COC in urine was investigated using samples of urine stored in freezers 
and refrigerators. The analytes were extracted from urine using a solid-phase extraction technique and analyzed by gas 
chromatography-flame ionization detection method. Results: COC concentrations decreased while BE concentrations 
increased. AME concentrations remained stable. Conclusions: The temperature and the duration of storage are decisive 
in COC hydrolyzing. This study suggests that AME concentrations are not correlated to either storage duration or with 
storage temperature and AME is more stable than COC.
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Resumo
Contexto: Cocaína (COC) e/ou metabólitos tem sido analisados em urina e outros fluidos biológicos para se determinar 
o uso de COC. A COC está sujeita a numerosas reações de biotransformação e degradação. Indivíduos que fumam crack 
estão expostos ao éster metilanidroecgonina (AME), que pode ser empregado como marcador de uso desta droga. Não 
há referências na literatura a respeito da estabilidade deste analito em urina humana. No organismo a COC é rapidamente 
biotransformada em outros metabólitos por meio de processos químicos e enzimáticos e o principal metabólito urinário é a 
benzoilecgonina (BE). Objetivos: O objetivo deste estudo foi determinar o efeito do tempo e da temperatura na estabilidade 
da COC, BE e do AME em urina humana. Métodos: A estabilidade do AME, BE e COC em urina foi investigada por inter-
médio do armazenamento da urina em freezer e em geladeira. Os analitos foram extraídos pela técnica de extração em fase 
sólida e analisados por cromatografia gasosa acoplada ao detector por ionização em chama. Resultados: As concentrações 
de COC decresceram enquanto as BE aumentaram. As concentrações de AME se mantiveram estáveis. Conclusões: A 
temperatura e o tempo de armazenamento são decisivos na hidrólise da COC. Este estudo sugere que as concentrações de 
AME não estão correlacionadas com o tempo ou a temperatura de armazenamento e o AME é mais estável que a COC.  
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Introduction
The detection and measurement of drugs and metabo-
lites in biological specimens provides law enforcement 
officers with an objective means for the diagnosis of 
drug abuse by human subjects. The widespread abuse 
of cocaine has forensic implications, major in crimes. 
Typically, urine and other biological tissues have been 
analyzed for COC and/or metabolites to detect COC use. 
COC and BE can be detected in urine within 6-8 hr and 
2-3 days, respectively (Wolff, 2006). Recently, smoking 
cocaine base (crack) has become popular, mostly in 
North American and some Latin American countries 
mainly due to its rapid delivery of drug to the brain. 
Smoking also causes an intense craving for additional 
drug. During the smoking of crack, AME is formed as 
a result of the elimination of benzoic acid from COC 
under the high temperature conditions of pyrolysis and 
this analyte has been identified in the urine of crack 
smokers (Zhang and Foltz, 1990; Paul et al., 1999; Kintz 
et al., 1995; Shimomura et al., 2001), with most subjects 
excreting substantial amounts of AME averaging ap-
proximately half the molar amounts of COC excreted 
during a 48 hr collections period (Jacob et al., 1990). In 
general, AME concentrations are much higher in urine 
than in other biological specimens (Shimomura et al., 
2001). AME may be metabolized by similar routes as 
COC. It is known that AME can be hydrolysed enzymati-
cally to anhydroecgonine (AE) in human plasma due 
to butyryl cholinesterase and nonenzimatic processes 
(Fandino et al., 2002a), and in vitro degradation has been 
observed in sheep plasma (Sheidweiler et al., 2000). In 
contrast, in a study on the metabolism using microsomal 
preparations from rat organs the nonenzymatic hydro-
lysis at physiological pH was negligible in comparison 
to the enzymatic route (Fandino et al., 2002b). 
The stability study of analytes in biological samples 
is a prerequisite for reliable quantification. Additionally, 
provide more information for adequate interpretation 
of results. Presently, only urine is routinely collected 
and analyzed in workplace drug testing programs 
(SAMHSA, 2004), this biological fluid provides a some-
what longer time frame, is a noninvasive specimen 
and analytes concentrations are higher than in other 
biological specimens. 
Materials and methods 
Sample preparation – The urine samples were acidi-
fied using phosphate buffer (pH 5.5-6.0). AME, BE and 
COC stability was investigated by adding analytes to 
urine from stock solutions (100 µg/mL). The analytes 
concentrations were 1.0 µg/mL and the volume of 
sample were 100 mL. The samples were separate in 
twenty aliquots (5 mL, each), four samples were ana-
lyzed immediately, and eight samples were stored by 
refrigerating and the others in freezer. After 15 days 
eight samples were analyzed, four from refrigerated and 
four from freezer. The same procedure was repeated 
after 30 days. Extraction/derivatization procedure - 
The extraction columns were conditioned with methanol 
(3 mL) and phosphate buffer, pH 5.5-6.0 (3 mL). The 
urine samples were poured on to the columns and al-
lowed to pass through by gravity flow. The columns were 
washed with 2 mL of phosphate buffer, 6 mL of deionized 
water, and 3 mL of 0.1 M HCl. The columns were dried 
for 5 min using suction. The methanol was added (9 mL) 
and the columns were again aspirated to dryness for 2 
min using suction and the analytes were extracted from 
the columns with 3 mL of dichloromethane-methanol-
ammonium hydroxide (14.8 M) (90:10:2, v/v/v). The 
eluates were dried at 40ºC under nitrogen. Pentafluo-
ropropionic anhydride (PFPA) (70 µL) and 2,2,3,3,3-
pentafluoro-1-propanol (PFPOH) (40 µL) were added 
and the vials were immediately capped, vortex-mixed, 
and incubated at 70ºC for 10 min. Derivatized mixtures 
were dried under nitrogen. The solutions were evapo-
rated to dryness under nitrogen at 40ºC. The analytes 
were recovered in 200 µL of ethyl acetate, vortex-mixed 
and dried again to remove the excess of derivatizatizing 
reagents. The extracts were recovered in 50 µL of ethyl 
acetate and analyzed by GC-FID (gas chromatographic 
coupled to a flame ionization detector). AME and COC 
are not derivatized under these conditions, only BE. 
Instrumentation – The analyses were performed on 
a Intralab CG-FID Model 3300. The GC-FID analyses 
employed at 30-m x 0.25-mm i.d. DB-5 capillary column 
with a film thickness of 0.25 µm. The carrier gas was 
nitrogen. After a splitless injection, the oven tempera-
ture was maintained at 140°C for 4 min, and the oven 
temperature was programmed to 160°C at 30°C/min, 
maintained for 3 min, and 220°C at 30°C/min for 5 min. 
Assay Validation – AME, BE and COC assay linearity 
was investigated by adding analytes to urine from a sex 
drug-free volunteer (blank urine) from duplicate stock 
solutions (100 µg/mL for each analyte) diluted from 
calibrators weighed out separately. The expected AME 
concentrations of the linearity samples were 0.2; 0.5; 1.0; 
2.0; 3.0 and 4.0 µg/mL for AME, 0.1; 0.2; 0.5; 1.0; 2.0 and 
3.0 µg/mL for BE and 0.1; 0.5; 1.0; 2.0; 3.0; 4.0 and 5.0 
µg/mL for COC. The sample was analyzed as described 
above, and a linear regression analysis was performed 
(analyte area/internal standard area). The correlation 
coefficients were 0.9979, 0.9934 and 0.9977 for AME, BE 
and COC, respectively. The limit of detection were 0.1 
µg/mL for AME and 0.05 µg/mL for BE and COC and 
the limit of quantification were 0.2 µg/mL for AME and 
0.1 µg/mL for BE and COC. The extraction yield was 
90%, 85% and 99% for AME, BE and COC, respectively. 
The intra-day precision were 10.26%; 13.10% and 2.20% 
for AME, BE and COC, respectively (3.0 µg/mL urine, 
n = 6). The inter-day precision were 14.45%; 11.73% and 
10.40% for AME, BE and COC, respectively (3.0 µg/mL 
urine, n = 6 days). Evaluation of the artifact produc-
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tion in the assay of AME in urine using GC-FID 
– Is possible to convert COC to AME under high tem-
peratures encountered in the GC injection (Toennes et 
al., 2003). The injector of the GC-FID used in this study 
was maintained at 230ºC and a clean liner was inserted. 
The high temperature in the injector necessitated the 
evaluation of the production of the artifact, this evalu-
ation was accomplished by adding COC stock solution 
(1 g/L) to a blank urine (0.5, 2.0, 4.0, 5.0, 50 and 100 µg/
mL) in triplicate for each concentration. The samples 
was analyzed as describe above and the production of 
artifact monitored by formation AME.
Results
Artifactual production of AME could be excluded in 
urine with COC concentrations between 0.5 and 50 mg/L 
and the AME artifact was present only in urine with 
COC concentration 100 mg/L and the concentrations 
of AME in this samples were smaller than the limit of 
detection. The decreased COC media relative area (ana-
lyte/internal standard area ratios) after 30 days stored 
were 23% and 16% for the samples stored refrigerated 
and in freezer, respectively. Consequently, the increased 
BEC media relative area after 30 days stored were 66% 
and 33% for the samples stored by refrigerating and in 
freezer, respectively. AME concentrations in refrigerated 
and freezer incubation samples were stable, with media 
relative area varying between 10% and 12% of the starting 
concentration (Table 1). There were no significant dif-
ferences (Mann-Whitney test) in media relative areas 
of AME for the samples stored by refrigerating and in 
freezer for 15 days (p = 0.4705) and 30 days (p = 0.4705). 
Additionally, there were no significant differences be-
tween 15 and 30 days of stored (p = 0.3836). 
Discussion
AME is the principal thermal breakdown product of 
COC, it is not formed metabolically and therefore rec-
ognized as a specific marker for smoked cocaine (Paul 
et al., 1999; Shimomura et al., 2001). The distinction 
between the inhalation of cocaine and nasal insufflation 
or injection has forensic and medical implications. It has 
been shown that AME may also be formed as a thermal 
degradation product of cocaine, either during the free 
base inhalation of compound or during GC analysis 
(Toennes et al., 1999; Casale, 1992). The thermal deg-
radation could be a cis-elimination process mediating 
a cyclic transition state and involving a debenzoylation 
(Gonzalez et al., 1995). The presence of AME artifact 
could be excluded in urine with COC concentrations 
between 0.5 and 50 mg/L and the AME artifact was pres-
ent only in urine with COC concentration 100 mg/L and 
the concentrations of AME in this samples was smaller 
than the limit of detection. These results indicated the 
artifactual production of AME was not considered to be 
Table 1. Results of stability study of AME, BE and COC 
from spiked urine stored refrigerated and in freezer
Media relative area (N = 4)
AME BE COC
Hour zero 0.165 0.302 0.334
RSD % 14 15 4
Freezer
15 days 0.146 0.316 0.304
RSD % 7 7 5
% of variation (MRA) -12 +5 -9
30 days 0.149 0,401 0.280
RSD% 9 3 15
% of area variation -10 +33 -16
Refrigerated
15 days 0.153 0.433 0.259
RSD % 5 2 4
% of variation (MRA) -7 +43 -23
30 dias 0.147 0,500 0.256
RSD % 3 3 3
% of area variation -11 +66 -23
Legend: RSD-relative standard deviation; MRA: media relative area.
Figure 1. Effect of time on relative area of analytes stored refrigerated.
relevant. These results are consistent with the findings 
of Cone et al. (1994), that the formation of the AME 
found to be consistently less than 1% (injector port was 
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Figure 2. Effect of time on relative area of analytes stored in freezer.
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depends on the injection port type, so other analysts 
might experience a lower or higher degree (Toennes et 
al., 1999) and the use of a clean insert liner to minimize 
artifact production (Toennes et al., 2003).
Because BE is excreted over a longer period of time, 
its detection in biological specimens is utilized in most 
clinical and forensic investigations to infer cocaine use 
(Paul et al., 1999). In other hand, the stability study of 
analytes in urine provides additional information for 
adequate interpretation of results. Under moderate con-
ditions of pH, COC and BE will also be a stable product 
and a reliable marker for COC use. The nonenzymatic 
hydrolysis of COC to BE can be slowed or eliminated by 
acidifying the sample and storing it at 4ºC. Conversely, 
the rate of hydrolysis increases at higher pH or tem-
perature (Warner and Norman, 2000; Peterson et al., 
1995). In this study the high degradation of cocaine 
with a higher time of incubation (30 days) and stored 
in freezer can be indicate that the temperature and the 
time of stored are decisive in COC hydrolyzing. In other 
hand, speed of extraction and pH conditions is important 
considerations since COC is highly susceptible to hy-
drolysis, particularly under high pH conditions. Liquid-
liquid extraction was not considered as a viable option 
because of time and pH considerations. Consequently, 
SPE techniques provided high recoveries. In this study 
the low temperature conditions was more effective to 
decrease the degradation.
This study suggests that AME concentrations are not 
correlating with the storage time of the urine samples or 
the temperature and AME is more stable than COC. This 
can be explained by the fact that the methylester group 
in AME is resonance-stabilized, probably the reason for 
its higher hydrolytic stability (Toennes et al., 2003).
 In cases where crack abuse was claimed and recent 
cocaine abuse was proved, this could be confirmed by 
the detection of AME. This analyte seems to be stable 
towards hydrolysis if urine specimens are refrigerated 
after collection and decrease pH to 6.0 for 30 days. 
Conclusions
The benzoylecgonine is a better biomarker for identifi-
cation of use cocaine because is excreted over a longer 
period of time and showed higher concentrations. Addi-
tionally, when hydrolysis of cocaine occurs is possible 
to detect benzoylecgonine to infer cocaine use. The 
temperature and time of storage are decisive in COC 
hydrolysis. 
AME is a specific biomarker for identification of 
use crack and is stable in urine specimens stored by 
refrigerating or in freezer after collection and decrease 
pH to 6.0 for 30 days.
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